Your browser doesn't support javascript.
loading
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines.
Gongora, Carlos A; Drobni, Zsofia D; Quinaglia Araujo Costa Silva, Thiago; Zafar, Amna; Gong, Jingyi; Zlotoff, Daniel A; Gilman, Hannah K; Hartmann, Sarah E; Sama, Supraja; Nikolaidou, Sofia; Suero-Abreu, Giselle Alexandra; Jacobsen, Eric; Abramson, Jeremy S; Hochberg, Ephraim; Barnes, Jeffrey; Armand, Philippe; Thavendiranathan, Paaladinesh; Nohria, Anju; Neilan, Tomas G.
Afiliação
  • Gongora CA; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Drobni ZD; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Quinaglia Araujo Costa Silva T; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Zafar A; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Gong J; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Zlotoff DA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Gilman HK; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Hartmann SE; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Sama S; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Nikolaidou S; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Suero-Abreu GA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Jacobsen E; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Abramson JS; Center for Lymphoma, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Hochberg E; Center for Lymphoma, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Barnes J; Center for Lymphoma, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Armand P; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Thavendiranathan P; Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, Canada.
  • Nohria A; Department of Cardiology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Neilan TG; Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: tneilan@mgh.harvard.edu.
JACC Heart Fail ; 10(8): 559-567, 2022 08.
Article em En | MEDLINE | ID: mdl-35902159
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JACC Heart Fail Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Simportadores / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: JACC Heart Fail Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos